Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group

This study has been completed.

First Received: September 12, 2005 Last Updated: May 7, 2006 History of Changes

Sponsors and Collaborators:	University Hospital, Ghent Scientific research fund Bruges
Information provided by:	University Hospital, Ghent
ClinicalTrials.gov Identifier:	NCT00221559

Purpose

Serum Zn status of patients with cystic fibrosis at diagnosis and one year later, compared to a healthy control group

Condition	Intervention
Cystic Fibrosis	Procedure: Blood sampling for determination of serum Zn

Genetics Home Reference related topics: cystic fibrosis

MedlinePlus related topics: Cystic Fibrosis

Study Type:	Observational
Study Design:	Screening, Cross-Sectional, Defined Population, Prospective Study
Official Title:	Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group

Further study details as provided by University Hospital, Ghent:

Estimated Enrollment:	0
Study Start Date:	September 2004

Detailed Description:

Serum Zn status of patients with cystic fibrosis at diagnosis and one year later, compared to a healthy control group

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria: - Diagnosis of cystic fibrosis Exclusion Criteria: -

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00221559

Locations

Sponsors and Collaborators

University Hospital, Ghent

Scientific research fund Bruges

Investigators

Principal Investigator:

Stephanie Van Biervliet, MD

University Hospital, Ghent

More Information

Additional Information:

Website University Hospital Ghent This link exits the ClinicalTrials.gov site

Publications:

Study ID Numbers:	UZGhent 001
Study First Received:	September 12, 2005
Last Updated:	May 7, 2006
ClinicalTrials.gov Identifier:	NCT00221559 History of Changes
Health Authority:	Belgium: Institutional Review Board

Study placed in the following topic categories:

Digestive System Diseases
Genetic Diseases, Inborn
Respiratory Tract Diseases
Cystic Fibrosis
Fibrosis

Lung Diseases
Infant, Newborn, Diseases
Pancreatic Diseases
Healthy

Additional relevant MeSH terms:

Pathologic Processes
Digestive System Diseases
Genetic Diseases, Inborn
Respiratory Tract Diseases
Cystic Fibrosis

Fibrosis
Lung Diseases
Infant, Newborn, Diseases
Pancreatic Diseases

ClinicalTrials.gov processed this record on May 06, 2009